Sunderhaus Allison, Imran Ramsha, Goudelock Amanda, Nassar Manon, Cooper Kendall, Patterson Dustin, Abdel Aziz May H
Fisch College of Pharmacy, The University of Texas at Tyler, Tyler, Texas, USA.
Department of Chemistry and Biochemistry, The University of Texas at Tyler, Tyler, Texas, USA.
Biotechnol Bioeng. 2021 Apr;118(4):1466-1475. doi: 10.1002/bit.27659. Epub 2021 Feb 4.
Epidermal growth factor receptor (EGFR) is a clinically validated target for a multitude of human cancers. The receptor is activated upon ligand binding through a critical dimerization step. Dimerization can be replicated in vitro by locally concentrating the receptor kinase domains on the surface of lipid-based vesicles. In this study we investigated the use of coiled coils to induce spontaneous receptor kinase domain dimerization in vitro to form non-membrane-bound artificial receptor mimics in solution. Two engineered forms of EGFR kinase domain fused to coiled coil complementary peptides were designed to self-associate upon mixing. Two fusion protein species (P3-EGFR and P4-EGFR) independently showed the same activity and polymerization profile known to exist with EGFR kinase domains. Upon mixing the two species, coiled coil heterodimers were formed that induced EGFR association to form dimers of the kinase domains. This was accompanied by 11.5-fold increase in the phosphorylation rate indicative of kinase domain activation equivalent to the levels achieved using vesicle localization and mimicking in vivo ligand-induced activation. This study presents a soluble tyrosine kinase receptor mimic capable of spontaneous in vitro activation that can facilitate functional and drug discovery studies for this clinically important receptor class.
表皮生长因子受体(EGFR)是多种人类癌症经临床验证的靶点。该受体通过关键的二聚化步骤在配体结合后被激活。二聚化可通过在脂质囊泡表面局部浓缩受体激酶结构域在体外进行复制。在本研究中,我们研究了利用卷曲螺旋在体外诱导受体激酶结构域自发二聚化,以在溶液中形成非膜结合的人工受体模拟物。设计了两种与卷曲螺旋互补肽融合的EGFR激酶结构域的工程形式,使其在混合时能自我缔合。两种融合蛋白(P3-EGFR和P4-EGFR)各自独立显示出与EGFR激酶结构域已知存在的相同活性和聚合特征。将这两种蛋白混合后,形成了卷曲螺旋异二聚体,其诱导EGFR缔合形成激酶结构域二聚体。这伴随着磷酸化速率提高11.5倍,表明激酶结构域被激活,其水平等同于使用囊泡定位并模拟体内配体诱导激活所达到的水平。本研究展示了一种能够在体外自发激活的可溶性酪氨酸激酶受体模拟物,它可促进针对这一具有临床重要性的受体类别的功能和药物发现研究。